Janice R. Andrews
According to exclusive sources from The Associated Press, the United States Drug Enforcement Administration (DEA) is preparing to reclassify marijuana in a historic step that could change American drug policy.
The proposed reclassification recognizes cannabis’ therapeutic benefits as well as its lesser potential for addiction when compared to other harmful substances. However, it falls short of complete legalization for recreational reasons.
This breakthrough is a key regulatory milestone that will be reviewed by the White House Office of Management and Budget. Once accepted, the DEA will hold a public comment period before implementing the change, which moves marijuana from Schedule I to Schedule III alongside drugs such as ketamine and certain steroids.
President Joe Biden’s request for a federal marijuana law review in 2022, together with efforts to pardon thousands of people convicted of marijuana possession, pave the way for this landmark decision. Biden’s administration intends to address the disproportionate impact of marijuana-related convictions, suggesting a significant shift in national drug policy.
The revelation, timed intentionally in an election year, may boost Biden’s support, particularly among younger populations. With growing bipartisan momentum, backed by public opinion polls showing majority support for legalization, the move reflects changing attitudes toward marijuana.
However, not all voices agree with the DEA’s decision. Some skeptics, including former DEA officers, warn of potential risks, citing marijuana’s reputation as a potentially gateway drug. Despite reasons for regulating marijuana similarly to alcohol, problems exist, including regulatory hurdles and international treaty commitments.
While this move promises to loosen prohibitions and boost the booming marijuana business, it also has significant legal and diplomatic ramifications. As the country navigates this dramatic shift, the ramifications will go far beyond drug policy, influencing the landscape of law enforcement, healthcare, and global relations.
